Can Vaping Help You Quit Smoking? What the Evidence Actually Shows (2026)

Executive Summary

The evidence is clear: nicotine vaping helps more smokers quit than nicotine replacement therapy (NRT) or cold turkey. A 2025 Cochrane review of 104 studies found 8 to 11 out of every 100 smokers who use nicotine e-cigarettes successfully quit, compared to 6 out of 100 using NRT. Yet the conversation has become deeply polarized. In May 2026, a landmark Carcinogenesis review classified nicotine-containing e-cigarettes as “likely carcinogenic to humans,” adding a new layer of complexity. Meanwhile, the UK actively promotes vaping for cessation, while the U.S. remains ambivalent. This article walks through the evidence, the risks, the policy divide, and a practical plan for smokers who want to quit using vaping.

What the Evidence Actually Says

Let’s start with the strongest evidence available and work outward.

The Cochrane Review (Updated 2025)

The Cochrane review is the gold standard for evidence-based medicine. Their latest update, published in 2025, analyzed 104 studies involving 30,366 participants, making it the most comprehensive assessment of e-cigarettes for smoking cessation ever conducted.

The key finding: nicotine e-cigarettes help more people quit smoking than nicotine replacement therapy (NRT). Specifically:

• For every 100 people using nicotine e-cigarettes to quit, 8 to 11 successfully stop for at least six months
• For every 100 people using NRT (patches, gum, lozenges), only 6 successfully stop
• For every 100 people using e-cigarettes without nicotine, only 6 stop
• For every 100 people using behavioral support only or no support, only 4 stop

The review also found that unwanted effects from nicotine e-cigarettes — most commonly throat and mouth irritation, cough, headache, and nausea — were similar to those experienced with NRT and tended to decrease over time. Serious adverse events were low across all groups.

The NEJM Trials: Hajek 2019 and Auer 2024

The landmark Hajek study published in the New England Journal of Medicine in 2019 remains one of the most rigorous trials on vaping for cessation. Researchers randomized 886 smokers to receive either a vape starter kit or their choice of NRT. Both groups received weekly behavioral support. After one year, 18.0% of the e-cigarette group had quit smoking, compared to 9.9% of the NRT group — nearly double the quit rate.

Then came Auer et al. in 2024, another NEJM randomized trial that tested a slightly different question: does combining e-cigarettes with standard smoking cessation counseling outperform counseling alone? Participants who received e-cigarettes plus counseling had significantly higher quit rates than those receiving counseling alone, reinforcing the Hajek findings and extending the evidence base to a different clinical context. The consistency across trials — two independent NEJM studies, different populations, same direction of effect — strengthens the case that the benefit is real.

UK Real-World Evidence: Swap to Stop

Britain has gone further than any country in integrating vaping into official smoking cessation strategy. The NHS “Swap to Stop” program provides free vape kits to smokers who want to quit, alongside behavioral support. Data from Action on Smoking and Health (ASH) for 2025 shows that over a million people in the UK quit smoking with a vape in 2025 alone — bringing the five-year total past 3 million. Among those who stopped smoking in the last five years, over half reported using a vape to do it. About a third of those have also stopped vaping, with an average vaping duration of roughly one year.

Professor Sanjay Agrawal, special advisor on tobacco at the Royal College of Physicians, put it plainly: “In the last few years almost all the patients I see who manage to quit smoking do so through vaping and without it I fear many of them would not have.”

The Swap to Stop program was expanded in 2025 to distribute through community partners and local authorities, not just pharmacies, making it easier for smokers in deprived areas — where smoking rates are highest — to access kits and support.

The Counterargument: What UCSD Found

The evidence isn’t one-sided. A 2025 University of California San Diego study led by Karen Messer concluded “Vaping Does Not Help U.S. Smokers Quit.” Analyzing population-level data from the U.S., the researchers found that smokers who used e-cigarettes were no more likely to quit than those who didn’t — a finding that appears to contradict the Cochrane and NEJM results.

Why the contradiction? The UCSD study analyzed real-world population data, not randomized controlled trials. The difference matters. In RCTs, participants receive standardized devices, nicotine levels, and support. In the real world, a smoker might buy a cheap convenience store disposable with inadequate nicotine, use it inconsistently, or dual-use with cigarettes. The UCSD results likely reflect how vaping is actually used in the U.S. — without guidance, without follow-up, and often with the wrong product. The Cochrane review’s higher quit rates reflect what happens when vaping is done right. Both findings can be true simultaneously, and together they tell a fuller story: vaping works as a cessation tool, and works best with proper guidance.

Summary Table

Method	6-Month Quit Rate	Evidence Level	Source
Nicotine e-cigarettes	8–11 per 100	High (RCTs + meta-analysis)	Cochrane, 2025
NRT (patches, gum)	6 per 100	High	Cochrane, 2025
E-cigs + counseling (NEJM)	18% at 1 yr (Hajek) / Significant benefit (Auer)	High (2 RCTs)	Hajek 2019, Auer 2024
UCSD population study	No significant benefit (US real-world)	Moderate (observational)	Messer et al. 2025
Cold turkey (unassisted)	3–5%	Observational	CDC estimates

Why Vaping Works — and Who It Works For

Quit rates are averages. Individual results vary wildly. Understanding why vaping works for some smokers and not others is more useful than citing overall percentages.

The Behavioral Match

Smoking isn’t just a chemical addiction. It’s a ritual — lighting up after a meal, stepping outside for a break, the hand-to-mouth motion, the inhale-exhale rhythm. NRT addresses the chemical dependency yet ignores the behavioral component. A nicotine patch delivers the drug yet gives you nothing to do with your hands.

Vaping mimics the ritual. You hold something, you inhale, you exhale something visible. For smokers where the behavioral pattern is deeply ingrained — especially those who’ve smoked for decades — this similarity matters. The mechanics of vaping closely replicate enough of the smoking experience to make the transition tolerable.

Nicotine Salts Changed Everything

Early e-cigarettes were terrible at delivering nicotine. First-generation cigalikes provided less nicotine per puff than a cigarette, leaving smokers under-dosed and frustrated. The game changed with nicotine salts — benzoic acid formulations that allow higher nicotine concentrations with a smoother throat hit. A pod system with 50 mg/mL nicotine salt can deliver nicotine to the brain at speeds approaching a cigarette. This matters because if the replacement doesn’t satisfy the craving, the smoker goes back to cigarettes. For a deeper look at what nicotine salts are and how they work, our dedicated guide covers the chemistry and practical use.

The Role of Flavors in Quitting

An often-overlooked factor is flavor. In May 2026, the FDA authorized five flavored e-cigarette products from Glas Inc. — including fruit flavors — marking the first time non-tobacco flavors received authorization through the PMTA pathway, contingent on age verification technology. This was a watershed moment.

Why do flavors matter for cessation? Survey data consistently shows that adult smokers who switch to vaping are more likely to succeed with non-tobacco flavors. Tobacco flavors remind them of smoking — often the very thing they’re trying to escape. Fruit, mint, and dessert flavors create psychological distance from the cigarette experience. The FDA’s shift suggests regulators are beginning to acknowledge what the data has shown for years: flavors help adult smokers quit, even as they also appeal to youth.

The Gradual Reduction Path

Most e-liquids come in a range of nicotine strengths: 0, 3, 6, 12, 20, and 50 mg/mL. This allows a stepped reduction approach that mirrors NRT with a critical difference: the behavioral component stays constant while the nicotine decreases. You’re not changing two variables at once (nicotine and habit), just one. Need guidance on choosing the right e-liquid and nicotine strength, our full guide breaks it down by smoking level and device type.

In practice, though, many vapers never step down. A 2026 ScienceLine report noted that former smokers often stay hooked on vaping long after switching. “People can feel like they have completely lost control, like they are vaping all the time,” said Megan Piper, a professor at the University of Wisconsin Center for Tobacco Research and Intervention. This is the honest trade-off: you may trade a smoking addiction for a vaping one.

Nicotine Strength: A Practical Guide

Choosing the right nicotine strength is the single most common failure point for smokers trying to quit with vaping. Here’s how to match your intake:

Your Smoking Level	Starting Nicotine Strength	Device Type
1 pack/day or more	50 mg/mL (5%) nicotine salt	Pod system (e.g., nicotine salt devices)
10–19 cigs/day	20–35 mg/mL nicotine salt	Pod system
Less than 10 cigs/day	12–20 mg/mL freebase or salt	Pod or pen style
Social/occasional smoker	3–6 mg/mL freebase	Any MTL device

For a more detailed breakdown of how vape nicotine compares to cigarette nicotine, our comparison guide explains the pharmacokinetics in plain language.

The goal in the first week is simple: eliminate cigarette cravings completely. Still reaching for cigarettes after a week? Increase your nicotine level. Feeling nauseous or dizzy? Decrease it. Getting this right in the first week is the difference between success and relapse.

The Perception Crisis

Here’s a statistic that should alarm public health professionals: in 2024, half of all adults surveyed by ASH believed vaping was as harmful or more harmful than smoking. A 2026 UT Southwestern study confirmed this trend is worsening — more adults now incorrectly believe e-cigarettes are more dangerous than cigarettes than at any point in the past decade. The proportion reached 30.4% in 2022, up from just 2.8% in 2012.

This is a problem because perception drives behavior. If a smoker believes vaping is just as harmful as smoking, why would they switch? They wouldn’t. They’d keep smoking. And smoking kills roughly 480,000 Americans annually.

David Abrams, a professor at NYU and leading tobacco harm reduction advocate, doesn’t mince words: “The misinformation, in some ways, is tantamount to murder. You are telling 13 million adult smokers: don’t switch unless you can fully commit, which leads to the statement, ‘either quit everything or die.'”

The misperception has multiple causes. Anti-vaping campaigns targeting youth — necessary campaigns, given that youth vaping remains a concern — had the side effect of frightening adult smokers away from a less harmful alternative. Media coverage of EVALI (the 2019 lung illness outbreak caused by vitamin E acetate in illicit THC cartridges, not legal nicotine vapes) cemented the association between vaping and lung damage in the public mind. And the erosion of trust in public health institutions during the pandemic has made it harder for evidence-based messages — like “vaping is less harmful than smoking” — to break through.

Understanding the Risks

Nobody credible claims vaping is safe. The honest framing is this: vaping is less harmful than smoking, not harmless. And the evidence base continues to evolve.

What We Know Now

Cardiovascular effects. A 2025 review in the American Journal of Physiology found measurable short-term vascular changes from e-cigarette use, though at lower magnitude than cigarette smoke.

Respiratory concerns. A 2025 Johns Hopkins analysis of large-scale medical records found that exclusive e-cigarette use was linked to higher rates of COPD and high blood pressure compared to non-users, though the risks were substantially lower than for smokers.

New Carcinogenicity Evidence (May 2026). This is the most significant new development. A comprehensive review published in Carcinogenesis by Stewart et al. (May 2026) classified nicotine-containing e-cigarettes as “likely carcinogenic to humans.” CNN covered the review prominently, and it represents the first major IARC-style risk assessment of vaping.

What does “likely carcinogenic” actually mean? The review identified several mechanisms by which e-cigarette aerosol could contribute to cancer risk — DNA damage from carbonyl compounds, oxidative stress, and inflammatory responses in lung tissue. The key qualifier is “likely” — not “known.” The review is a qualitative hazard assessment, meaning it identifies potential mechanisms and plausible risks, not a quantitative risk assessment that would tell us how many cases of cancer might actually occur. For context, tobacco smoking is classified as “carcinogenic to humans” (Group 1) with overwhelming epidemiological evidence. E-cigarettes have been placed in the “probably carcinogenic” (Group 2A) category — a classification that includes things like red meat, night shift work, and emissions from high-temperature frying.

This doesn’t mean vaping causes cancer at anywhere near the rate smoking does. It means the theoretical risk exists, and long-term users should be aware of it. Global vape regulations increasingly reflect this evolving risk assessment, with some countries tightening access based on precautionary principles.

Nicotine is addictive. It affects brain development through about age 25. No one under 25, no pregnant person, and no non-smoker should use nicotine in any form.

Dual use negates most of the benefit. Smoking and vaping simultaneously doesn’t meaningfully reduce harm. The benefit comes from complete substitution.

What Remains Unknown

• The effects of decades of inhalation of propylene glycol (PG), vegetable glycerin (VG), and flavoring compounds
• Whether certain flavors or device types carry higher risk than others
• Whether long-term vaping at low nicotine levels carries significantly different risk from short-term use
• The full scope of secondhand aerosol exposure
• The actual population-level cancer incidence from long-term vaping (which will take another 10-20 years to measure directly)

Putting Risk in Perspective

The most useful framework comes from the Royal College of Physicians and the National Academies of Sciences, both of which have concluded that while vaping is not without risk, the harm profile is substantially lower than combustible tobacco. Combustion creates thousands of chemicals — at least 70 known carcinogens — that simply don’t exist in e-cigarette aerosol at meaningful levels.

The practical question for a smoker weighing the choice is not “Is vaping safe?” (nothing is). The question is: “Compared to continuing to smoke, is switching to vaping likely to reduce my health risk?” The answer to that question is yes, substantially — even with the new carcinogenicity evidence on the table. That answer comes with the acknowledgment that the ideal outcome is quitting both entirely.

How Different Countries Approach Vaping for Cessation

The global split on vaping as a cessation tool has only widened in the past year.

Country	Stance on Vaping for Cessation	Key Policy (2026)
United Kingdom	Actively promoted	NHS provides free vape kits through “Swap to Stop” (expanded 2025). Tobacco and Vapes Bill passed — generational smoking ban effective January 2027. Disposable vapes banned June 2025.
United States	Ambivalent	FDA has not approved any e-cigarette as a cessation device, though it has authorized 45 ENDS products through PMTA (as of May 2026), including flavored products from Glas Inc. California CDPH declared vaping a “health threat” in 2026.
Australia	Prescription only	E-cigarettes available only with a doctor’s prescription since 2024. TGA imposed stricter safety standards from July 2025. Nicotine concentration limits and manufacturing quality controls.
New Zealand	Regulated access	Disposable vapes banned from June 2025. Nicotine concentration capped at 28.5 mg/mL. Retail display restrictions for tobacco shops. Vaping still available as cessation tool with marketing restrictions.
Canada	Conditional support	Health Canada acknowledges vaping is less harmful than smoking while warning non-smokers not to start. Nicotine concentration capped at 20 mg/mL (except for prescription).
India, Brazil, Thailand	Complete ban	All e-cigarettes prohibited. No legal access even for cessation. Possession can carry criminal penalties.

The UK’s position is the most evidence-driven. The Office for Health Improvement and Disparities publishes an annual evidence update on nicotine vaping. While Public Health England — the original source of the “95% less harmful” estimate — was dissolved in 2023, the NHS continues to actively promote vaping as a cessation tool, and smoking rates in England reached an all-time low of 11.9% in 2023.

The U.S. position remains cautious, partly because the FDA is caught between two mandates: reducing youth vaping and helping adult smokers quit. The agency has not approved any e-cigarette as a smoking cessation drug, though it has authorized over four dozen products through the PMTA pathway as less harmful alternatives to continued smoking. In a significant shift, the May 2026 authorization of Glas flavored products with age-verification technology suggests the FDA may be opening the door to a regulated market for non-tobacco flavors — provided manufacturers can demonstrate youth access mitigation.

A Complete Smoking Cessation Plan

Step 1: Choose Your Device

For quitting smoking, pod systems are the evidence-backed choice. They deliver nicotine efficiently through salt e-liquids, they’re simple to use, and they closely replicate the smoking experience. Avoid sub-ohm devices and box mods — they deliver too much vapor and are designed for hobbyists, not cessation. Considering disposables, our guide to the benefits and drawbacks of disposable vapes explains when they can work and when they won’t.

Step 2: Match Your Nicotine Level

Use the nicotine strength table above. Smoking a pack a day? Start with 50 mg/mL nicotine salt in a pod system. For those smoking less than 10 cigarettes daily, 10–20 mg/mL may be sufficient. The goal is to eliminate cravings, not to feel a buzz. Still reaching for cigarettes after a week? Increase your nicotine level.

Step 3: Set a Reduction Timeline

Most ex-smokers who switch to vaping take 3–12 months before they’re ready to reduce nicotine. Don’t rush.

• Month 1: Establish full substitution. No dual use.
• Month 3–6: Step down to the next nicotine strength (e.g., 50 → 25 mg/mL)
• Month 6–9: Step down again (25 → 12 mg/mL)
• Month 9–12: Move to 3–6 mg/mL or 0 mg/mL
• Month 12+: Transition off the device, or continue at 0 mg/mL to break the behavioral habit

ASH data shows the average successful quitter vapes for about a year before stopping entirely.

Step 4: Add Behavioral Support

The NEJM trials that found 18% quit rates? Every participant received weekly behavioral counseling alongside their vape. The Cochrane review’s higher quit rates also involved some form of support. Vaping alone is better than nothing, and vaping plus support is meaningfully better. Free resources include the CDC’s smokefree.gov, the NHS Stop Smoking Service (UK), and state quitlines (1-800-QUIT-NOW in the U.S.).

Step 5: Watch for Common Pitfalls

• Dual use: The most common failure mode. Complete substitution is necessary for meaningful harm reduction.
• Over-vaping: Unlike a cigarette — which has a natural endpoint when it burns down — a vape can be hit endlessly. Set boundaries: specific times, specific places.
• Never stepping down: It’s easy to stay at your starting nicotine level indefinitely. When your goal is to be nicotine-free, you need an intentional reduction plan.
• Relapse during stress: The number one trigger. Have a plan for stressful days that doesn’t involve buying a pack.

Step 6: The Endgame — Quitting Vaping Too

Once you’ve successfully switched from smoking to vaping, congratulations. That’s a major health win. Still, for most people, the goal isn’t to vape forever. Here’s how to approach the final taper:

• Switch to freebase nicotine when you reach the lowest salt-nic level. Freebase delivers a slower, less satisfying hit — which is actually helpful when you’re trying to wean off.
• Use zero-nicotine vapes for the last 2–3 months of the journey. This separates the behavioral habit (hand-to-mouth, inhale-exhale) from the chemical dependence, allowing you to break each one separately.
• Limit access — leave your vape in a different room, don’t carry it with you, and use it only in designated spots. This mimics the effort of going outside for a cigarette, which naturally reduces frequency.
• Set a quit date for the final stop — just like you did for cigarettes. Having a target helps.

Medical Options: Cytisinicline and Varenicline

For smokers who struggle to quit with vaping alone — or for vapers who want to quit vaping after switching — pharmacological options are emerging. Cytisinicline (a plant-based alkaloid from the laburnum tree) showed promise in the ORCA-V1 trial for vaping cessation, published in JAMA Internal Medicine in 2024. Participants using cytisinicline were significantly more likely to reduce or stop vaping compared to placebo, with good tolerability.

Varenicline (Chantix/Champix), already approved for smoking cessation, is also being studied for vaping cessation. A 2025 ICER report reviewed both medications and found cytisinicline particularly promising due to its lower cost and favorable side effect profile. These options matter because they complete the picture: first you quit smoking with vaping, then you quit vaping with pharmacological support if needed.

Neither is a substitute for a well-designed reduction plan on its own, for people who find themselves unable to step down, they’re worth discussing with a doctor.

Zero-Nicotine Vapes: A Role at the End

Zero-nicotine vapes exist and can play a role in the final stage of quitting — addressing the behavioral habit after the chemical addiction is resolved. Starting with zero nicotine from day one doesn’t work for most smokers, because the nicotine craving is what drives relapse. Use zero-nicotine products at the end of the journey, not the beginning.

FAQ

Can vaping actually help me quit smoking?

Yes. The best available evidence — a 2025 Cochrane review of 104 studies — found that nicotine e-cigarettes help more people quit smoking than nicotine replacement therapy. In the UK, ASH reports over 3 million people have quit smoking with a vape since 2020. Success depends on choosing the right device, matching your nicotine level, and having a plan to step down.

Is vaping safer than smoking?

Vaping is less harmful than smoking — not safe, less harmful. The absence of combustion eliminates thousands of chemicals present in cigarette smoke. However, a May 2026 review in Carcinogenesis classified nicotine e-cigarettes as “likely carcinogenic to humans,” putting them in the same hazard category as red meat and night shift work. The comparison between smoking and vaping isn’t close on the harm scale — vaping still carries health risks.

Will I just get addicted to vaping instead?

Possibly. The NEJM trial found that 80% of vapers who quit smoking were still using their e-cigarette at one year. However, ASH data shows that about a third of people who quit smoking with a vape eventually stop vaping too, with an average duration of about one year. The key is having an intentional step-down plan, not just switching one addiction for another permanently.

Why do some doctors say vaping doesn’t help you quit?

Three reasons. First, the FDA hasn’t approved e-cigarettes as cessation drugs in the U.S., so American doctors are constrained in what they can officially recommend. Second, studies like the UCSD 2025 analysis show that in real-world U.S. conditions — where smokers often use the wrong devices and receive no support — vaping may not help. Third, the medical community is legitimately concerned about long-term risks we can’t yet fully quantify, especially following the new carcinogenicity evidence.

What’s the best vape for quitting smoking?

A pod system with nicotine salt e-liquid. Pod systems replicate the smoking experience closely, nicotine salts deliver efficiently, and the simplicity means fewer variables. Avoid disposables for cessation — they don’t allow you to control nicotine strength, which is essential for a step-down plan. Our best pod vapes for quitting guide has specific recommendations.

How long does it take to quit smoking with a vape?

Most people who successfully quit take 3–12 months to become smoke-free and an additional 3–12 months to stop vaping entirely. ASH data puts the average vaping duration at about one year before quitting both. Rushing the initial transition from cigarettes is the most common cause of relapse.

What if I’ve tried vaping before and went back to smoking?

The most common reason for relapse is inadequate nicotine delivery. Modern nicotine salt pod systems deliver nicotine far more effectively than older devices. It may be worth trying again with current-generation hardware and a proper nicotine strength.

Does vaping cause cancer?

A May 2026 review in Carcinogenesis classified nicotine e-cigarettes as “likely carcinogenic to humans” (Group 2A), citing mechanisms like DNA damage from carbonyl compounds and oxidative stress in lung tissue. This is a real concern, though the hazard classification needs perspective: Group 2A also includes red meat and emissions from high-temperature frying. By contrast, tobacco smoking is Group 1 — “carcinogenic to humans” — with overwhelming epidemiological evidence of causing millions of cancer cases. The Carcinogenesis review identifies a plausible risk — it’s not evidence that vaping causes cancer at anywhere near the rate smoking does. Long-term users should be aware of the risk, and the ideal is to quit both entirely.

What’s the best way to quit vaping once I’ve quit smoking?

Start by gradually reducing your nicotine strength over 3–6 months. When you reach the lowest level, switch to zero-nicotine e-liquid to separate behavioral habit from chemical dependence. Set boundaries on when and where you vape. Once you’re stable on zero-nicotine, set a quit date to stop using the device entirely. Medical options like cytisinicline may help when you struggle with the final step.

Are flavored vapes better than tobacco flavors for quitting?

Evidence suggests yes. Survey data shows adult smokers who switch to non-tobacco flavors — fruit, mint, dessert — are more likely to quit successfully than those using tobacco flavors. The FDA’s May 2026 authorization of five flavored e-cigarette products from Glas Inc. marks a significant policy shift, recognizing that flavors can aid cessation when combined with age-verification technology.

Can I use varenicline or cytisinicline to help quit vaping?

Cytisinicline has shown promise. The ORCA-V1 trial (JAMA Internal Medicine, 2024) found it significantly helped people reduce or stop vaping compared to placebo, with good tolerability. Varenicline (Chantix) is also being studied for vaping cessation. These medications are prescription-only in most countries and should be discussed with a doctor. They won’t replace a reduction plan, though they can help when you struggle to step down on your own.

Do disposable vapes help you quit smoking?

They can, though they’re not ideal for a structured cessation plan. Disposables don’t let you adjust nicotine strength, which is critical for a step-down approach. The UK banned disposable vapes from June 2025, partly over environmental concerns. The benefits of disposables — convenience and low upfront cost — are real, though for cessation, a reusable pod system gives you more control.

This article is for informational purposes only and does not constitute medical advice. Considering using vaping to quit smoking, consult a healthcare professional. Nicotine is addictive and not intended for non-smokers, pregnant individuals, or people under 21.